Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety, tolerability and pharmacodynamics of pumosetrag in patients with gastroesophageal reflux disease, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pumosetrag (pumosetrag)

Snippet

Sponsor: Edusa Pharmaceuticals, Inc. | Conditions: Gastroesophageal Reflux Disease | Phase 2 | Status: COMPLETED